Skip to content
Biomarker Report
www.BiomarkerReport.com
Home
Research
CLN3 is required for the clearance of glycerophosphodiesters from lysosomes
Sep 21, 2022
-
Finally, we found elevated levels of glycerophosphoinositol in the cerebrospinal fluid of patients with Batten disease, suggesting the potential use of glycerophosphoinositol as a disease biomarker.